The authors provide an overview of current and on-going chimeric antigen receptor (CAR) T cell clinical studies in pancreatic cancer and the major challenges and strategies to improve CAR T cell efficacy.
[Molecular Therapy-Oncolytics]
7992332
{7992332:AAAAAAAA}
apa
50
1
171355
https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
